Investigational Site Number : 2760006

Ulm 89081

2 studies enrolling now · 3 studies all time

What they study most

Colitis Ulcerative, Immunoglobulin G4 Related Disease

Studies at this site

• A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease — Recruiting now
• A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis — Recruiting now
• Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis — Running, not enrolling